Xiaojing Xu

1.8k total citations
76 papers, 1.3k citations indexed

About

Xiaojing Xu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xiaojing Xu has authored 76 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 30 papers in Molecular Biology and 18 papers in Cancer Research. Recurrent topics in Xiaojing Xu's work include Colorectal Cancer Treatments and Studies (11 papers), Gastric Cancer Management and Outcomes (8 papers) and Genetic factors in colorectal cancer (6 papers). Xiaojing Xu is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Gastric Cancer Management and Outcomes (8 papers) and Genetic factors in colorectal cancer (6 papers). Xiaojing Xu collaborates with scholars based in China, United States and New Zealand. Xiaojing Xu's co-authors include Huanxiang Zhang, Tianshu Liu, Zhaoqian Liu, Boting Zhou, Yiyi Yu, Peixin Huang, Jinglin Xia, Hong‐Hao Zhou, Yingchun Zhao and Ji‐Ye Yin and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xiaojing Xu

75 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojing Xu China 22 572 428 282 182 136 76 1.3k
Yan Xiong China 24 869 1.5× 291 0.7× 272 1.0× 218 1.2× 61 0.4× 122 1.8k
Sae‐Ock Oh South Korea 25 1.1k 1.9× 408 1.0× 414 1.5× 116 0.6× 130 1.0× 84 1.8k
Constantinos M. Mikelis United States 26 1.3k 2.2× 453 1.1× 415 1.5× 144 0.8× 79 0.6× 75 2.2k
Ze Zhang China 21 700 1.2× 325 0.8× 322 1.1× 192 1.1× 66 0.5× 65 1.4k
Yanfei Jia China 24 890 1.6× 345 0.8× 385 1.4× 190 1.0× 81 0.6× 102 1.6k
Hua Wu China 30 1.3k 2.2× 543 1.3× 594 2.1× 229 1.3× 142 1.0× 80 2.5k
Simonetta Astigiano Italy 25 797 1.4× 406 0.9× 322 1.1× 110 0.6× 52 0.4× 54 1.7k
André Luiz Mencalha Brazil 22 859 1.5× 375 0.9× 315 1.1× 148 0.8× 101 0.7× 107 1.8k
Célia Gomes Portugal 28 1.2k 2.1× 733 1.7× 434 1.5× 110 0.6× 58 0.4× 73 2.2k
Maria Grazia Totaro Italy 12 1.2k 2.2× 668 1.6× 332 1.2× 101 0.6× 81 0.6× 18 2.5k

Countries citing papers authored by Xiaojing Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaojing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Xu more than expected).

Fields of papers citing papers by Xiaojing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Xu. The network helps show where Xiaojing Xu may publish in the future.

Co-authorship network of co-authors of Xiaojing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Xu. A scholar is included among the top collaborators of Xiaojing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Xu. Xiaojing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Shuo, Da Li, Fan Zeng, et al.. (2025). Prevalence and risk factors of long COVID-19 persisting for 2 years in Hainan Province: a population-based prospective study. Scientific Reports. 15(1). 369–369. 2 indexed citations
2.
Zhong, Wentao, Xinhong Wang, Jinming Liu, et al.. (2025). Development of a 3D nanofiber neurocomplex from MSCs-derived neuron-like cells for spinal cord injury regeneration and functional recovery. Chemical Engineering Journal. 521. 166728–166728. 1 indexed citations
3.
Xu, Xiaojing, Luoyan Ai, Li Liang, et al.. (2024). Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study. Nature Communications. 15(1). 7255–7255. 16 indexed citations
4.
An, Na, Fengyi Chen, Huan Chen, et al.. (2023). Downregulation of RCN1 promotes pyroptosis in acute myeloid leukemia cells. Molecular Oncology. 17(12). 2584–2602. 4 indexed citations
5.
Wu, Yanyou, Shijie Hao, Xiaojing Xu, et al.. (2023). A novel computational method enables RNA editome profiling during human hematopoiesis from scRNA-seq data. Scientific Reports. 13(1). 10335–10335. 5 indexed citations
6.
Xu, Xiaojing, et al.. (2023). Asparaginyl endopeptidase contributes to cetuximab resistance via MEK/ERK signaling in RAS wide-type metastatic colorectal cancer. Clinical & Translational Oncology. 25(3). 776–785. 4 indexed citations
7.
Xu, Xiaojing, Yiyi Yu, Yuehong Cui, et al.. (2023). Efficacy and safety of tislelizumab plus cetuximab and irinotecan in patients with previously treated RAS wild-type advanced colorectal cancer: A phase II, single-arm study.. Journal of Clinical Oncology. 41(4_suppl). 125–125. 1 indexed citations
8.
Xu, Xiaojing, Ke Peng, Xun Sun, et al.. (2022). Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway. Oncogenesis. 11(1). 58–58. 5 indexed citations
9.
Xu, Xiaojing, et al.. (2022). Efficacy and safety of regorafenib and fruquintinib as third-line treatment for colorectal cancer: a narrative review. Translational Cancer Research. 11(1). 276–287. 17 indexed citations
10.
Li, Wei, Yueqi Wang, Qian Li, et al.. (2022). Toripalimab in advanced biliary tract cancer. The Innovation. 3(4). 100255–100255. 12 indexed citations
11.
12.
Zhao, Jing, Wenxi Hua, Yudi Chen, et al.. (2019). <p>Effect of <em>XPC</em> polymorphisms on the response to platinum-based chemotherapy: a meta-analysis</p>. OncoTargets and Therapy. Volume 12. 3839–3848. 6 indexed citations
13.
Zhong, Wentao, Xiaojing Xu, Li J, et al.. (2019). Lysophosphatidic acid guides the homing of transplanted olfactory ensheathing cells to the lesion site after spinal cord injury in rats. Experimental Cell Research. 379(1). 65–72. 8 indexed citations
14.
Fang, Tingting, Yuan Fang, Xiaojing Xu, et al.. (2018). Actinidia chinensis Planch root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition. Journal of Ethnopharmacology. 231. 474–485. 29 indexed citations
15.
Chen, Erbao, Xuan Qin, Ke Peng, et al.. (2018). Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis. Cellular Physiology and Biochemistry. 45(5). 1731–1746. 20 indexed citations
16.
Xu, Xiaojing, Peixin Huang, Biwei Yang, Xiangdong Wang, & Jinglin Xia. (2014). Roles of CXCL5 on migration and invasion of liver cancer cells. Journal of Translational Medicine. 12(1). 193–193. 23 indexed citations
17.
Qu, Jian, Ying Zhang, Xiao‐Yuan Mao, et al.. (2013). Gene‐Wide Tagging Study of the Association Between KCNT1 Polymorphisms and the Susceptibility and Efficacy of Genetic Generalized Epilepsy in Chinese Population. CNS Neuroscience & Therapeutics. 20(2). 140–146. 17 indexed citations
18.
Zhou, Boting, Ji‐Ye Yin, Guoliang Li, et al.. (2012). Effects of SCN1A and GABA Receptor Genetic Polymorphisms on Carbamazepine Tolerability and Efficacy in Chinese Patients with Partial Seizures: 2‐Year Longitudinal Clinical Follow‐Up. CNS Neuroscience & Therapeutics. 18(7). 566–572. 41 indexed citations
19.
Yin, Ji‐Ye, et al.. (2011). ABCC1 polymorphism Arg723Gln (2168G > A) is associated with lung cancer susceptibility in a Chinese population. Clinical and Experimental Pharmacology and Physiology. 38(9). 632–637. 8 indexed citations
20.
Xu, Xiaojing, et al.. (2011). Differentiation of neural stem cells influences their chemotactic responses to vascular endothelial growth factor. Journal of Neuroscience Research. 89(8). 1173–1184. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Xiong Breakdown of academic impact, for papers by Sae‐Ock Oh Breakdown of academic impact, for papers by Constantinos M. Mikelis Breakdown of academic impact, for papers by Ze Zhang Breakdown of academic impact, for papers by Yanfei Jia Breakdown of academic impact, for papers by Hua Wu Breakdown of academic impact, for papers by Simonetta Astigiano Breakdown of academic impact, for papers by André Luiz Mencalha Breakdown of academic impact, for papers by Célia Gomes Breakdown of academic impact, for papers by Maria Grazia Totaro
Rankless by CCL
2026